文献速递新发突发、热带与寄生虫病细菌感染、耐药与抗菌药物

资源有限地区耐药疟疾检测:高效高通量监测青蒿素及配伍药物耐药性

Detection of drug-resistant malaria in resource-limited settings: efficient and high-throughput surveillance of artemisinin and partner drug resistance.
PubMed 文献 · J Antimicrob Chemother · 2024-01-01

研究开发了一套最低人力和物资需求的现场实验方案,用于监测恶性疟原虫对青蒿素及配伍药物的耐药性。qPCR-based SNP检测与DNA测序相比,在检测乌干达两种常见青蒿素耐药突变C469Y和A675V时灵敏度和特异度均为100%,且1小时内可检出突变。培养样本经96孔滤纸板干保存运输后,ELISA复溶检测与直接ELISA结果高度一致(Pearson相关系数0.984,95%CI 0.975-0.990)。

要点

  • qPCR-based SNP检测可在1小时内检出青蒿素耐药突变,灵敏度与特异度均为100%。
  • 干保存运输后ELISA复溶检测与直接ELISA高度相关(r=0.984,95%CI 0.975-0.990)。
  • 该方案可提高现场实验效率并加速全球耐药监测。

核心结论

  • 大规模可持续监测对追踪快速传播的耐药疟疾迫切必要;在资源有限的疟疾流行区,程序的简便性和可行性尤为重要;该方案结合qPCR快速检测(也适用于青蒿素耐药的即时诊断)与离体培养的集中分析,可提高现场实验效率并加速全球耐药监测。

研究设计与样本

  • 开发了一套用于现场研究的实验包,具有最低的人力和物资需求。

主要发现

  • qPCR-based SNP检测在检测乌干达两种常见青蒿素耐药突变C469Y和A675V时,与DNA测序相比灵敏度和特异度均为100%,可在1小时内检出突变并便于后续流程的样本选择。
  • 配伍药物药敏试验中,培养样本在96孔滤纸板上干保存并运送至中心实验室,复溶后ELISA检测寄生虫生长,良好重现了直接ELISA的结果(Pearson相关系数0.984;95%CI 0.975-0.990),减少了现场显著工作量。

关键数值与推荐

  • qPCR-based SNP检测与DNA测序相比,检测C469Y和A675V突变的灵敏度和特异度均为100%。
  • 干保存复溶ELISA与直接ELISA的Pearson相关系数为0.984(95%CI 0.975-0.990)。

临床怎么用

  • 该方案可用于疟疾流行区的青蒿素耐药现场筛查和配伍药物药敏监测,qPCR快速检测也适用于青蒿素耐药的即时诊断。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Artemisinin-resistant Plasmodium falciparum malaria is currently spreading globally, including in Africa. Artemisinin resistance also leads to resistance to partner drugs used in artemisinin-based combination therapies. Sequencing of kelch13, which is associated with artemisinin resistance, culture-based partner drug susceptibility tests, and ELISA-based growth measurement are conventionally used to monitor resistance; however, their application is challenging in resource-limited settings. METHODS: An experimental package for field studies with minimum human/material requirements was developed. RESULTS: First, qPCR-based SNP assay was applied in artemisinin resistance screening, which can detect mutations within 1 h and facilitate sample selection for subsequent processes. It had 100% sensitivity and specificity compared with DNA sequencing in the detection of the two common artemisinin resistance mutations in Uganda, C469Y and A675V. Moreover, in the partner drug susceptibility test, the cultured samples were dry-preserved on a 96-well filter paper plate and shipped to the central laboratory. Parasite growth was measured by ELISA using redissolved samples. It well reproduced the results of direct ELISA, reducing significant workload in the field (Pearson correlation coefficient: 0.984; 95% CI: 0.975-0.990). CONCLUSIONS: Large-scale and sustainable monitoring is required urgently to track rapidly spreading drug-resistant malaria. In malaria-endemic areas, where research resources are often limited, simplicity and feasibility of the procedure is especially important. Our approach combines a qPCR-based rapid test, which is also applicable to point-of-care diagnosis of artemisinin resistance and centralized analysis of ex vivo culture. The approach could improve efficiency of field experiments and accelerate global drug resistance surveillance.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Fukuda N, Yoshida N, Balikagala B, et al. Detection of drug-resistant malaria in resource-limited settings: efficient and high-throughput surveillance of artemisinin and partner drug resistance. J Antimicrob Chemother. 2024. PMID: 38661223. doi:10.1093/jac/dkae120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。